Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prasugrel in the poststroke cohort of the TRITON Trial: the clear and present danger.

× No keyword cloud information.

5 in total

1. Prevalence of contraindications and conditions for precaution for prasugrel administration in a real world acute coronary syndrome population.

Authors: Dimitrios Alexopoulos; Ioanna Xanthopoulou; Panagiota Mylona; Angelos Perperis; Aggeliki Panagiotou; Gerasimos Dimitropoulos; Grigorios Tsigkas; George Hahalis; Periklis Davlouros
Journal: J Thromb Thrombolysis Date: 2011-10 Impact factor: 2.300

Review 2. Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention.

Authors: Alexandria Stringberg; Ryan Camden; Kathryn Qualls; Syed H Naqvi
Journal: Mo Med Date: 2019 Jul-Aug

Review 3. Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.

Authors: Ralph Weber; Hans-Christoph Diener
Journal: J Cell Mol Med Date: 2010-10 Impact factor: 5.310

4. The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients.

Authors: Katarina D Kovacevic; Stefan Greisenegger; Agnes Langer; Georg Gelbenegger; Nina Buchtele; Ingrid Pabinger; Karin Petroczi; Shuhao Zhu; James C Gilbert; Bernd Jilma
Journal: Sci Rep Date: 2021-02-04 Impact factor: 4.379

Review 5. Antiplatelet Use in Ischemic Stroke.

Authors: Marharyta Kamarova; Sheharyar Baig; Hamish Patel; Kimberley Monks; Mohammed Wasay; Ali Ali; Jessica Redgrave; Arshad Majid; Simon M Bell
Journal: Ann Pharmacother Date: 2022-01-29 Impact factor: 3.463

5 in total